Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer model.
Sci Adv
; 8(47): eadd1187, 2022 11 25.
Article
in En
| MEDLINE
| ID: mdl-36417514
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Chimeric Antigen
/
Neoplasms
Limits:
Animals
Language:
En
Journal:
Sci Adv
Year:
2022
Document type:
Article
Affiliation country:
Singapur